nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—Skin striae—Bleomycin—testicular cancer	0.0986	0.0986	CcSEcCtD
Prednicarbate—Telangiectasia—Methotrexate—testicular cancer	0.0538	0.0538	CcSEcCtD
Prednicarbate—Eruption—Dactinomycin—testicular cancer	0.0475	0.0475	CcSEcCtD
Prednicarbate—Folliculitis—Dactinomycin—testicular cancer	0.0465	0.0465	CcSEcCtD
Prednicarbate—Secondary infection—Epirubicin—testicular cancer	0.0404	0.0404	CcSEcCtD
Prednicarbate—Secondary infection—Doxorubicin—testicular cancer	0.0373	0.0373	CcSEcCtD
Prednicarbate—Leukoderma—Methotrexate—testicular cancer	0.0298	0.0298	CcSEcCtD
Prednicarbate—Infection—Carboplatin—testicular cancer	0.0279	0.0279	CcSEcCtD
Prednicarbate—Leukoderma—Epirubicin—testicular cancer	0.0279	0.0279	CcSEcCtD
Prednicarbate—Leukoderma—Doxorubicin—testicular cancer	0.0258	0.0258	CcSEcCtD
Prednicarbate—Pain—Carboplatin—testicular cancer	0.024	0.024	CcSEcCtD
Prednicarbate—Eruption—Methotrexate—testicular cancer	0.0206	0.0206	CcSEcCtD
Prednicarbate—Folliculitis—Methotrexate—testicular cancer	0.0202	0.0202	CcSEcCtD
Prednicarbate—Eruption—Epirubicin—testicular cancer	0.0193	0.0193	CcSEcCtD
Prednicarbate—Folliculitis—Epirubicin—testicular cancer	0.0189	0.0189	CcSEcCtD
Prednicarbate—Eruption—Doxorubicin—testicular cancer	0.0178	0.0178	CcSEcCtD
Prednicarbate—Folliculitis—Doxorubicin—testicular cancer	0.0175	0.0175	CcSEcCtD
Prednicarbate—Infection—Chlorambucil—testicular cancer	0.0144	0.0144	CcSEcCtD
Prednicarbate—Pain—Chlorambucil—testicular cancer	0.0124	0.0124	CcSEcCtD
Prednicarbate—Paraesthesia—Vinblastine—testicular cancer	0.0119	0.0119	CcSEcCtD
Prednicarbate—Dermatitis contact—Epirubicin—testicular cancer	0.0117	0.0117	CcSEcCtD
Prednicarbate—Urticaria—Chlorambucil—testicular cancer	0.0115	0.0115	CcSEcCtD
Prednicarbate—Pain—Vinblastine—testicular cancer	0.0113	0.0113	CcSEcCtD
Prednicarbate—Oedema—Bleomycin—testicular cancer	0.0112	0.0112	CcSEcCtD
Prednicarbate—Infection—Bleomycin—testicular cancer	0.0111	0.0111	CcSEcCtD
Prednicarbate—Dermatitis contact—Doxorubicin—testicular cancer	0.0108	0.0108	CcSEcCtD
Prednicarbate—Oedema—Dactinomycin—testicular cancer	0.0104	0.0104	CcSEcCtD
Prednicarbate—Infection—Dactinomycin—testicular cancer	0.0104	0.0104	CcSEcCtD
Prednicarbate—Pruritus—Chlorambucil—testicular cancer	0.0102	0.0102	CcSEcCtD
Prednicarbate—Paraesthesia—Bleomycin—testicular cancer	0.01	0.01	CcSEcCtD
Prednicarbate—Pain—Bleomycin—testicular cancer	0.00956	0.00956	CcSEcCtD
Prednicarbate—Oedema—Ifosfamide—testicular cancer	0.00956	0.00956	CcSEcCtD
Prednicarbate—Infection—Ifosfamide—testicular cancer	0.0095	0.0095	CcSEcCtD
Prednicarbate—Pain—Dactinomycin—testicular cancer	0.00892	0.00892	CcSEcCtD
Prednicarbate—Urticaria—Bleomycin—testicular cancer	0.00888	0.00888	CcSEcCtD
Prednicarbate—Paraesthesia—Ifosfamide—testicular cancer	0.00858	0.00858	CcSEcCtD
Prednicarbate—Oedema—Cisplatin—testicular cancer	0.00824	0.00824	CcSEcCtD
Prednicarbate—Infection—Cisplatin—testicular cancer	0.00819	0.00819	CcSEcCtD
Prednicarbate—Pain—Ifosfamide—testicular cancer	0.00817	0.00817	CcSEcCtD
Prednicarbate—Pruritus—Bleomycin—testicular cancer	0.00791	0.00791	CcSEcCtD
Prednicarbate—Urticaria—Ifosfamide—testicular cancer	0.00759	0.00759	CcSEcCtD
Prednicarbate—Infection—Etoposide—testicular cancer	0.0075	0.0075	CcSEcCtD
Prednicarbate—Paraesthesia—Cisplatin—testicular cancer	0.0074	0.0074	CcSEcCtD
Prednicarbate—Rash—Bleomycin—testicular cancer	0.00705	0.00705	CcSEcCtD
Prednicarbate—Pain—Cisplatin—testicular cancer	0.00705	0.00705	CcSEcCtD
Prednicarbate—Dermatitis—Bleomycin—testicular cancer	0.00704	0.00704	CcSEcCtD
Prednicarbate—Paraesthesia—Etoposide—testicular cancer	0.00678	0.00678	CcSEcCtD
Prednicarbate—Pruritus—Ifosfamide—testicular cancer	0.00676	0.00676	CcSEcCtD
Prednicarbate—Rash—Dactinomycin—testicular cancer	0.00658	0.00658	CcSEcCtD
Prednicarbate—Pain—Etoposide—testicular cancer	0.00646	0.00646	CcSEcCtD
Prednicarbate—Rash—Ifosfamide—testicular cancer	0.00603	0.00603	CcSEcCtD
Prednicarbate—Dermatitis—Ifosfamide—testicular cancer	0.00602	0.00602	CcSEcCtD
Prednicarbate—Urticaria—Etoposide—testicular cancer	0.006	0.006	CcSEcCtD
Prednicarbate—Pruritus—Etoposide—testicular cancer	0.00534	0.00534	CcSEcCtD
Prednicarbate—Rash—Cisplatin—testicular cancer	0.0052	0.0052	CcSEcCtD
Prednicarbate—Dermatitis—Cisplatin—testicular cancer	0.00519	0.00519	CcSEcCtD
Prednicarbate—Rash—Etoposide—testicular cancer	0.00476	0.00476	CcSEcCtD
Prednicarbate—Dermatitis—Etoposide—testicular cancer	0.00476	0.00476	CcSEcCtD
Prednicarbate—Infection—Methotrexate—testicular cancer	0.00449	0.00449	CcSEcCtD
Prednicarbate—Oedema—Epirubicin—testicular cancer	0.00423	0.00423	CcSEcCtD
Prednicarbate—Infection—Epirubicin—testicular cancer	0.0042	0.0042	CcSEcCtD
Prednicarbate—Paraesthesia—Methotrexate—testicular cancer	0.00406	0.00406	CcSEcCtD
Prednicarbate—Oedema—Doxorubicin—testicular cancer	0.00392	0.00392	CcSEcCtD
Prednicarbate—Infection—Doxorubicin—testicular cancer	0.00389	0.00389	CcSEcCtD
Prednicarbate—Pain—Methotrexate—testicular cancer	0.00387	0.00387	CcSEcCtD
Prednicarbate—Paraesthesia—Epirubicin—testicular cancer	0.0038	0.0038	CcSEcCtD
Prednicarbate—Pain—Epirubicin—testicular cancer	0.00362	0.00362	CcSEcCtD
Prednicarbate—Urticaria—Methotrexate—testicular cancer	0.00359	0.00359	CcSEcCtD
Prednicarbate—Paraesthesia—Doxorubicin—testicular cancer	0.00352	0.00352	CcSEcCtD
Prednicarbate—Urticaria—Epirubicin—testicular cancer	0.00336	0.00336	CcSEcCtD
Prednicarbate—Pain—Doxorubicin—testicular cancer	0.00335	0.00335	CcSEcCtD
Prednicarbate—Pruritus—Methotrexate—testicular cancer	0.0032	0.0032	CcSEcCtD
Prednicarbate—Urticaria—Doxorubicin—testicular cancer	0.00311	0.00311	CcSEcCtD
Prednicarbate—Pruritus—Epirubicin—testicular cancer	0.00299	0.00299	CcSEcCtD
Prednicarbate—Rash—Methotrexate—testicular cancer	0.00285	0.00285	CcSEcCtD
Prednicarbate—Dermatitis—Methotrexate—testicular cancer	0.00285	0.00285	CcSEcCtD
Prednicarbate—Pruritus—Doxorubicin—testicular cancer	0.00277	0.00277	CcSEcCtD
Prednicarbate—Rash—Epirubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Prednicarbate—Dermatitis—Epirubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Prednicarbate—Rash—Doxorubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
Prednicarbate—Dermatitis—Doxorubicin—testicular cancer	0.00247	0.00247	CcSEcCtD
